cancer screening
The McGill University team is advancing a test, dubbed DOvEEgene, which sequences DNA from a uterine brush sample to detect cancer-associated mutations.
In an indirect comparison study by researchers in Germany, a fecal immunochemical test showed similar sensitivity and specificity as Exact Sciences' Cologuard Plus test.
Mainz Biomed, Thermo Fisher Scientific to Develop Colorectal Cancer Screening Test
The collaboration will enable Mainz Biomed to harness Thermo Fisher’s resources to develop a new version of its mRNA-based colorectal cancer screening test.
The company hopes to attract investors to fund its next steps after publishing early data from a training and validation study using public miRNA data.
Tencent Invests $30M in Early Cancer Detection Firm Insighta
Hong Kong-based Prenetics, which had a 50 percent stake in Insighta, sold some of its secondary shares and will now hold a 35 percent stake in the company.